Global Primary Biliary Cirrhosis Drug Market Research Report 2015-2025
- HEY3829510
- 76 Pages
- April 2020
- Healthcare
The global Primary Biliary Cirrhosis Drug market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Clinic
Hospital
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Primary Biliary Cirrhosis Drug Picture
1.1.2 Specifications
Table Product Specifications of Primary Biliary Cirrhosis Drug
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market by Type, 2011-2022 (USD Million)
1.2.1.1 Budesonide
Table Budesonide Overview
1.2.1.2 FFP-104
Table FFP-104 Overview
1.2.1.3 GSK-2330672
Table GSK-2330672 Overview
1.2.1.4 MBX-8025
Table MBX-8025 Overview
1.2.1.5 NGM-282
Table NGM-282 Overview
1.2.1.6 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market by Application, 2011-2022 (USD Million)
1.2.2.1 Clinic
Table Clinic Overview
1.2.2.2 Hospital
Table Hospital Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Primary Biliary Cirrhosis Drug Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Primary Biliary Cirrhosis Drug
2.2 Upstream
Table Cost of Primary Biliary Cirrhosis Drug
Figure Manufacturing Process of Primary Biliary Cirrhosis Drug
2.3 Market
2.3.1 SWOT
Figure SWOT of Primary Biliary Cirrhosis Drug
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Primary Biliary Cirrhosis Drug
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Primary Biliary Cirrhosis Drug
3.4 Market Entry
Table Market Entry of Primary Biliary Cirrhosis Drug
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Budesonide Market, 2013-2018
Figure Budesonide Market Size and Growth, 2015-2019 (USD Million)
Figure Budesonide Market Size and Growth, 2015-2019 (in Volume)
Table Budesonide CAGR by Revenue and Volume, 2015-2019
4.1.2 FFP-104 Market, 2013-2018
Figure FFP-104 Market Size and Growth, 2015-2019 (USD Million)
Figure FFP-104 Market Size and Growth, 2015-2019 (in Volume)
Table FFP-104 CAGR by Revenue and Volume, 2015-2019
4.1.3 GSK-2330672 Market, 2013-2018
Figure GSK-2330672 Market Size and Growth, 2015-2019 (USD Million)
Figure GSK-2330672 Market Size and Growth, 2015-2019 (in Volume)
Table GSK-2330672 CAGR by Revenue and Volume, 2015-2019
4.1.4 MBX-8025 Market, 2013-2018
Figure MBX-8025 Market Size and Growth, 2015-2019 (USD Million)
Figure MBX-8025 Market Size and Growth, 2015-2019 (in Volume)
Table MBX-8025 CAGR by Revenue and Volume, 2015-2019
4.1.5 NGM-282 Market, 2013-2018
Figure NGM-282 Market Size and Growth, 2015-2019 (USD Million)
Figure NGM-282 Market Size and Growth, 2015-2019 (in Volume)
Table NGM-282 CAGR by Revenue and Volume, 2015-2019
4.1.6 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Others Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Budesonide Market Forecast, 2020-2025
Figure Budesonide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Budesonide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Budesonide CAGR by Revenue and Volume, 2012-2024
4.2.2 FFP-104 Market Forecast, 2020-2025
Figure FFP-104 Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure FFP-104 Market Estimates and Forecasts, 2020-2025 (in Volume)
Table FFP-104 CAGR by Revenue and Volume, 2012-2024
4.2.3 GSK-2330672 Market Forecast, 2020-2025
Figure GSK-2330672 Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure GSK-2330672 Market Estimates and Forecasts, 2020-2025 (in Volume)
Table GSK-2330672 CAGR by Revenue and Volume, 2012-2024
4.2.4 MBX-8025 Market Forecast, 2020-2025
Figure MBX-8025 Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure MBX-8025 Market Estimates and Forecasts, 2020-2025 (in Volume)
Table MBX-8025 CAGR by Revenue and Volume, 2012-2024
4.2.5 NGM-282 Market Forecast, 2020-2025
Figure NGM-282 Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure NGM-282 Market Estimates and Forecasts, 2020-2025 (in Volume)
Table NGM-282 CAGR by Revenue and Volume, 2012-2024
4.2.6 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Clinic Market, 2013-2018
Figure Clinic Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2015-2019
5.1.2 Hospital Market, 2013-2018
Figure Hospital Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2015-2019
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Clinic Market Forecast, 2020-2025
Figure Clinic Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2020-2025
5.2.2 Hospital Market Forecast, 2020-2025
Figure Hospital Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Primary Biliary Cirrhosis Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Primary Biliary Cirrhosis Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Primary Biliary Cirrhosis Drug Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Primary Biliary Cirrhosis Drug Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 AlbireoPharma
Table AlbireoPharma Profile List
Table Microecological Modulator Operating Data of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 CymaBay Therapeutics, Inc.
Table CymaBay Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Dr. Falk Pharma GmbH
Table Dr. Falk Pharma GmbH Profile List
Table Microecological Modulator Operating Data of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Enanta Pharmaceuticals, Inc.
Table Enanta Pharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 GlaxoSmithKline Plc
Table GlaxoSmithKline Plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Intercept Pharmaceuticals, Inc.
Table Intercept Pharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 MediGene AG
Table MediGene AG Profile List
Table Microecological Modulator Operating Data of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 NGM Biopharmaceuticals, Inc.
Table NGM Biopharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Virobay Inc.
Table Virobay Inc. Profile List
Table Microecological Modulator Operating Data of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Primary Biliary Cirrhosis Drug
Table Products Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market by Type, 2011-2022 (USD Million)
Table Budesonide Overview
Table FFP-104 Overview
Table GSK-2330672 Overview
Table MBX-8025 Overview
Table NGM-282 Overview
Table Others Overview
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market by Application, 2011-2022 (USD Million)
Table Clinic Overview
Table Hospital Overview
Table Others Overview
Table Global Primary Biliary Cirrhosis Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Primary Biliary Cirrhosis Drug
Table Market Dynamics
Table Policy of Primary Biliary Cirrhosis Drug
Table GDP of Major Countries
Table Technology of Primary Biliary Cirrhosis Drug
Table Market Entry of Primary Biliary Cirrhosis Drug
Table Budesonide CAGR by Revenue and Volume, 2015-2019
Table FFP-104 CAGR by Revenue and Volume, 2015-2019
Table GSK-2330672 CAGR by Revenue and Volume, 2015-2019
Table MBX-8025 CAGR by Revenue and Volume, 2015-2019
Table NGM-282 CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Budesonide CAGR by Revenue and Volume, 2012-2024
Table FFP-104 CAGR by Revenue and Volume, 2012-2024
Table GSK-2330672 CAGR by Revenue and Volume, 2012-2024
Table MBX-8025 CAGR by Revenue and Volume, 2012-2024
Table NGM-282 CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Clinic CAGR by Revenue and Volume, 2015-2019
Table Hospital CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Clinic CAGR by Revenue and Volume, 2020-2025
Table Hospital CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Primary Biliary Cirrhosis Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Primary Biliary Cirrhosis Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Primary Biliary Cirrhosis Drug Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table AlbireoPharma Profile List
Table Microecological Modulator Operating Data of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CymaBay Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma GmbH Profile List
Table Microecological Modulator Operating Data of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Enanta Pharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intercept Pharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MediGene AG Profile List
Table Microecological Modulator Operating Data of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NGM Biopharmaceuticals, Inc. Profile List
Table Microecological Modulator Operating Data of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Virobay Inc. Profile List
Table Microecological Modulator Operating Data of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
